MedPath

Acupressure of the ear for fatigue, sleep problems and anxiety in cancer patients treated with chemotherapy

Not Applicable
Completed
Conditions
Fatigue, sleep disturbance and anxiety in lung cancer patients with no severe complications
Mental and Behavioural Disorders
Registration Number
ISRCTN16408424
Lead Sponsor
Suzhou Municipal Science and Technology Bureau
Brief Summary

2019 results in https://pubmed.ncbi.nlm.nih.gov/31836594/ (added 23/11/2020)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria

1. Aged 18-75 years
2. Receiving conventional chemotherapy for lung cancer
3. Diagnosed with CRF using the diagnostic standards of the International Statistical Classification of Diseases and Related Health Problems 10th Revision and showed CRF =4 on a 0-10 numerical rating scale
4. No infection, injury or ulcers around the acupoint
5. No previous participation in AA or any fatigue-related intervention
6. No cognitively impairment
7. Willing to participate

Exclusion Criteria

Patients who had pleural effusion and other severe complications (such as severe anemia, severe organic diseases or dysfunction of heart, brain, or kidney) were excluded

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cancer-related fatigue (CRF) was assessed by the Cancer Fatigue Scale - Chinese version (CFS-C) using a numerical rating scale ranging from 0 to 10, with 10 indicating severe CRF and =4 indicating clinically significant fatigue. CRF was measured at baseline and at the end of the whole intervention, i.e. after the patients received three cycles of therapy.
Secondary Outcome Measures
NameTimeMethod
<br> 1. Sleep quality and quantity in the past month was assessed using the Pittsburgh Sleep Quality Index (PSQI)<br> 2. Anxiety was assessed using the Self-rating Anxiety Scale (SAS)<br> Sleep disturbance and anxiety were measured at baseline and at the end of the whole intervention, i.e. after the patients received three cycles of therapy.<br>
© Copyright 2025. All Rights Reserved by MedPath